Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | EVP and CMO | April 22, 2020 | April 24, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date April 22, 2020 · Filed April 24, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,719 |
Ending reported balance
After 2020-04-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-04-22 · Grant · Acquired 19,893 · Balance 92,532 F1: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Row 2 · 2020-04-22 · Tax withholding · Disposed 6,813 · Balance 85,719 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2020 Filed Apr 24, 2020 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,813 | $1.96 | $13,353.48 |
DisclosureSEC source: 0001127602-20-014487 · form4.xml · nonDerivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,719 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 19,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014487 · form4.xml · nonDerivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,532 F1 · kind: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 23,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · derivative · entry 9 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,927 Underlying: Common Stock · 23,463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · derivative · entry 8 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,570 Underlying: Common Stock · 8,570 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · derivative · entry 7 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,585 Underlying: Common Stock · 2,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · derivative · entry 6 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 13,305 | $2.77 | $36,854.85 |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · nonDerivative · entry 5 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,639 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 23,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · nonDerivative · entry 4 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · nonDerivative · entry 3 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · nonDerivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008962 · form4.xml · nonDerivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:07 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 247,220 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001127602-20-004591 · form4.xml · derivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,220 Underlying: Common Stock · 247,220 shares Expires 2030-02-06 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:07 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 82,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004591 · form4.xml · derivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,410 Underlying: Common Stock · 82,410 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · derivative · entry 9 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,140 Underlying: Common Stock · 8,570 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · derivative · entry 8 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,170 Underlying: Common Stock · 2,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · derivative · entry 7 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,228 Underlying: Common Stock · 4,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · derivative · entry 6 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 6,809 | $5.51 | $37,517.59 |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · nonDerivative · entry 5 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,098 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · nonDerivative · entry 4 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · nonDerivative · entry 3 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · nonDerivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-009261 · form4.xml · nonDerivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:05 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 70,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004879 · form4.xml · derivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,390 Underlying: Common Stock · 70,390 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 23:05 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 130,710 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001127602-19-004879 · form4.xml · derivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,710 Underlying: Common Stock · 130,710 shares Expires 2029-02-07 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · derivative · entry 9 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,755 Underlying: Common Stock · 2,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · derivative · entry 8 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,455 Underlying: Common Stock · 4,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · derivative · entry 7 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,550 Underlying: Common Stock · 4,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,821 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · derivative · entry 6 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,821 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 4,822 | $8.53 | $41,131.66 |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · nonDerivative · entry 5 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,975 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · nonDerivative · entry 4 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · nonDerivative · entry 3 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · nonDerivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,821 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-009728 · form4.xml · nonDerivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 22:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 72,330 | $0.00 Strike: $9.79 | $0.00 |
DisclosureSEC source: 0001127602-18-005201 · form4.xml · derivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,330 Underlying: Common Stock · 72,330 shares Expires 2028-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2019) and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 22:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 25,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005201 · form4.xml · derivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,710 Underlying: Common Stock · 25,710 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F2 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 4,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · derivative · entry 9 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,683 Underlying: Common Stock · 4,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 4,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · derivative · entry 8 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 Underlying: Common Stock · 4,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 2,822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · derivative · entry 7 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,821 Underlying: Common Stock · 2,822 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units (Phantom Stock) · Derivative | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · derivative · entry 6 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 5,252 | $16.45 | $86,395.40 |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · nonDerivative · entry 5 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,613 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · nonDerivative · entry 4 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · nonDerivative · entry 3 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · nonDerivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 23:49 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-009394 · form4.xml · nonDerivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:25 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units (Phantom Stock) · Derivative | 10,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005421 · form4.xml · derivative · entry 2 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,340 Underlying: Common Stock · 10,340 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:25 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 41,370 | $0.00 Strike: $14.44 | $0.00 |
DisclosureSEC source: 0001127602-17-005421 · form4.xml · derivative · entry 1 Lapuerta Pablo · CIK 0001516368 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,370 Underlying: Common Stock · 41,370 shares Expires 2027-02-09 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.